Europe | Daiichi Sankyo

Featured Stories

Would you like to work for Daiichi Sankyo and be an active member of our European family?
read more...

We are committed to improving awareness around cardiovascular disease and better patient care across Europe.
read more...

Our corporate video provides you with an insight into our company, our Japanese roots, our global history and pathways to innovation and care for patients.

Featured News

Date	Description
01/17/2022 Oncology	ENHERTU® Granted Priority Review in the U.S. for Patients with HER2 Positive Metastatic Breast Cancer Treated with a Prior Anti-HER2-Based Regimen	PDF
12/28/2021 Oncology	Trastuzumab Deruxtecan Type II Variation Application Validated by EMA for Patients with HER2 Positive Metastatic Breast Cancer Treated with a Prior Anti-HER2-Based Regimen	PDF
12/23/2021 Oncology	Patritumab Deruxtecan Granted U.S. FDA Breakthrough Therapy Designation in Patients with Metastatic EGFR-Mutated Non-Small Cell Lung Cancer	PDF
12/23/2021 Oncology	DESTINY-Lung04 Phase 3 Trial of ENHERTU® Initiated in Patients with Previously Untreated HER2 Mutant Metastatic Non-Small Cell Lung Cancer	PDF
12/13/2021 Oncology	Valemetostat Pivotal Data Shows Promising Response Rates in Patients with Adult T-Cell Leukemia/Lymphoma	PDF
show all

Career

We Care for Every Heartbeat

Cookie preferences tool

Career

We Care for Every Heartbeat